Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 91396101000001111 | Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 91396201000001116 | Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Is a | Secukinumab 150mg/1ml solution for injection pre-filled syringes | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | Secukinumab | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has dispensed dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Is a | Cosentyx | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has specific active ingredient | Secukinumab | false | Inferred relationship | Existential restriction modifier | ||
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) 2 pre-filled disposable injection | Has AMP | False | Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR